The white matter is a pro-differentiative niche for glioblastoma

[1]  Mariella G. Filbin,et al.  An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma , 2019, Cell.

[2]  V. Miron,et al.  The pro-remyelination properties of microglia in the central nervous system , 2019, Nature Reviews Neurology.

[3]  B. Popko,et al.  Molecular Control of Oligodendrocyte Development , 2019, Trends in Neurosciences.

[4]  Tracy T Batchelor,et al.  Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium , 2018, Nature Biomedical Engineering.

[5]  A. Philpott,et al.  The developmental origin of brain tumours: a cellular and molecular framework , 2018, Development.

[6]  M. Wegner,et al.  Sox8 and Sox10 jointly maintain myelin gene expression in oligodendrocytes , 2018, Glia.

[7]  S. Parrinello,et al.  Vascular regulation of glioma stem-like cells: a balancing act , 2017, Current Opinion in Neurobiology.

[8]  Richard A. Moore,et al.  Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy , 2017, Nature.

[9]  Gary D Bader,et al.  ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells. , 2017, Cell stem cell.

[10]  Edward F. Chang,et al.  Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. , 2017, Cancer cell.

[11]  K. Monk,et al.  G Protein-Coupled Receptors in Myelinating Glia. , 2016, Trends in pharmacological sciences.

[12]  N. Quan,et al.  Neuroinflammation: the devil is in the details , 2016, Journal of neurochemistry.

[13]  E. Chang,et al.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.

[14]  G. Bergers,et al.  Glioblastoma: Defining Tumor Niches. , 2015, Trends in cancer.

[15]  E. Kostenis,et al.  The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via Gαi/o and Its Downstream Effector Molecules* , 2015, The Journal of Biological Chemistry.

[16]  Thomas E. Bartlett,et al.  Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest , 2015, Stem cell reports.

[17]  A. Lloyd,et al.  Macrophage-Induced Blood Vessels Guide Schwann Cell-Mediated Regeneration of Peripheral Nerves , 2015, Cell.

[18]  B. Beuthien-Baumann,et al.  Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs. , 2015, The British journal of radiology.

[19]  J. Rich,et al.  Cancer stem cells in glioblastoma , 2015, Genes & development.

[20]  Volker Hovestadt,et al.  Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling , 2015, Nature Communications.

[21]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[22]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[23]  A. Fernandes,et al.  Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination. , 2014, Biochimica et biophysica acta.

[24]  Harald Sontheimer,et al.  A neurocentric perspective on glioma invasion , 2014, Nature Reviews Neuroscience.

[25]  M. Gilbert,et al.  Advances in treating glioblastoma , 2014, F1000prime reports.

[26]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[27]  Ming-xing Miao,et al.  Protective effect of pranlukast on Aβ₁₋₄₂-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1. , 2014, The international journal of neuropsychopharmacology.

[28]  Åsa K. Björklund,et al.  Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.

[29]  M. Wegner,et al.  Sox appeal – Sox10 attracts epigenetic and transcriptional regulators in myelinating glia , 2013, Biological chemistry.

[30]  N. Cordes,et al.  Invasion as target for therapy of glioblastoma multiforme. , 2013, Biochimica et biophysica acta.

[31]  V. Silva-Vargas,et al.  Adult neural stem cells and their niche: a dynamic duo during homeostasis, regeneration, and aging , 2013, Current Opinion in Neurobiology.

[32]  Daniel Schulz,et al.  Decoding Signaling and Function of the Orphan G Protein–Coupled Receptor GPR17 with a Small-Molecule Agonist , 2013, Science Signaling.

[33]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[34]  M. Wegner,et al.  The Transcription Factors Sox10 and Myrf Define an Essential Regulatory Network Module in Differentiating Oligodendrocytes , 2013, PLoS genetics.

[35]  F. de Castro,et al.  Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology , 2013, Cellular and Molecular Life Sciences.

[36]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[37]  David T. W. Jones,et al.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.

[38]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.

[39]  David H Rowitch,et al.  Astrocytes and disease: a neurodevelopmental perspective. , 2012, Genes & development.

[40]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[41]  M. Georgescu,et al.  Invasive glioblastoma cells acquire stemness and increased Akt activation. , 2010, Neoplasia.

[42]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[43]  Nitin J. Karandikar,et al.  The oligodendrocyte-specific G-protein coupled receptor GPR17 is a cell-intrinsic timer of myelination , 2009, Nature Neuroscience.

[44]  W. Pavan,et al.  Frequent mutations in the MITF pathway in melanoma , 2009, Pigment cell & melanoma research.

[45]  Mark Bernstein,et al.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. , 2009, Cell stem cell.

[46]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[47]  G. Maira,et al.  Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution , 2009, Oncogene.

[48]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[49]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[50]  G. Broggi,et al.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.

[51]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[52]  Austin G Smith,et al.  Niche-Independent Symmetrical Self-Renewal of a Mammalian Tissue Stem Cell , 2005, PLoS biology.

[53]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[54]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[55]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[56]  M. Wegner,et al.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. , 2002, Genes & development.

[57]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[58]  D. Raible,et al.  Induction of oligodendrocyte differentiation by activators of adenylate cyclase , 1990, Journal of neuroscience research.

[59]  H. Scherer.  Structural Development in Gliomas , 1938 .

[60]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[61]  S.J. Kuzminski.  Devil in the details , 2011, Nature.

[62]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[63]  Tanja Woyke,et al.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. , 2005, Neoplasia.

[64]  S. Brown,et al.  Balancing act. , 1996, The Canadian nurse.

[65]  J. Trosko,et al.  AN INTEGRATIVE MODEL , 1978 .